Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model
Takao Ukaji, … , Osamu Nureki, Kazusaku Kamiya
Takao Ukaji, … , Osamu Nureki, Kazusaku Kamiya
Published March 10, 2025
Citation Information: JCI Insight. 2025;10(5):e185193. https://doi.org/10.1172/jci.insight.185193.
View: Text | PDF
Research Article Genetics Therapeutics

AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model

  • Text
  • PDF
Abstract

Mutations in the gap junction β2 (GJB2) gene, which encodes connexin 26, are the leading cause of genetic deafness. These mutations are characterized by the degeneration and fragmentation of gap junctions and gap junction plaques (GJPs) composed of connexin 26. Dominant-negative mutations of GJB2, such as R75W, cause syndromic hearing loss and palmoplantar keratoderma. We previously reported that the R75W mutation, a single-base substitution where C is replaced by T, causes fragmentation of GJPs. Therefore, an adenine base editor (ABE), which enables A-to-G base conversions, can potentially be useful for the treatment of this genetic disease. Here, we report that an all-in-one adeno-associated virus (AAV) vector, which includes a compact ABE (SaCas9-NNG-ABE8e) with broad targeting range, and a sgRNA targeting the R75W mutation in GJB2 corrected this pathogenic mutation and facilitated the recovery of the gap junction intercellular communication network of GJPs. In a transgenic mouse model with the GJB2 R75W mutation, AAV-mediated base editing also restored the fragmented GJPs to orderly outlines in cochlear supporting cells. Our findings suggest that an ABE-based base-editing strategy could be an optimal treatment for the dominant form of GJB2-related hearing loss, GJB2-related skin diseases, and other deafness-related mutations, especially single-base substitutions.

Authors

Takao Ukaji, Daisuke Arai, Harumi Tsutsumi, Ryoya Nakagawa, Fumihiko Matsumoto, Katsuhisa Ikeda, Osamu Nureki, Kazusaku Kamiya

×

Figure 2

Analysis of the base-editing efficacy.

Options: View larger image (or click on image) Download as PowerPoint
Analysis of the base-editing efficacy.
(A) Strategy for assessing the ba...
(A) Strategy for assessing the base-editing efficiency for the mutation GJB2 R75W. (B) Representative results from direct genome sequencing after base editing via SaABE#1 to #5 or CjABE#6. The sequence at the bottom is the forward sequence. Red arrows indicate correction of the target site, and gray arrows indicate bystander editing. n = 3 technical replicates, representative of 3 independent experiments. (C) Representative images of EGFP+ cells expressing CX26 (red) and forming GJPs after base-editing plasmid transfection. Arrowheads indicate extensive GJPs in EGFP-expressing cells after base editing. Scale bar: 10 μm. (D) Representative images of GJPs after base editing by SaABE or CjABE with each sgRNA. HeLa/CX26 R75W cells were transfected with each base-editing plasmid vector. Negative control cells were left untreated. After transfection for 48 hours, EGFP+ cells were sorted, cultured for 1 week, and resorted to collect the EGFP– cells as samples. Samples were seeded into 96-well plates and cultured for 4 days. Samples were then fixed, permeabilized, and incubated with anti-CX26, followed by incubation with Alexa Flour 488–conjugated anti-rabbit IgG and Alexa Flour 555–conjugated cholera toxin subunit B, and then counterstained with DAPI. n = 3 technical replicates, representative of 3 independent experiments. Scale bar: 20 μm. (E–H) Quantitative length (E), area (F), form factor (G), and LAF (H) data presented in D. Box-and-whisker plots show median, interquartile range, and minimum and maximum values; isolated dots beyond the whiskers correspond to outliers defined as a value that is smaller than the lower quartile −1.5 × the interquartile range or larger than the upper quartile +1.5 times the interquartile range. Each value was normalized to the value obtained for HeLa/CX26 R75W cells (untreated). n = at least 70 analyzed per group. Statistical significance was determined with Kruskal-Wallis test with Dunn’s multiple comparisons test. *P < 0.05, **P < 0.01, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts